Response to Letter to the Editor

Affiliations

¹ Discovery and Early Pipeline Statistics, Abbvie, Inc., North Chicago, Illinoiis.
² Thoracic Oncology, Hospital Grosshansdorf, Grosshansdorf, Germany. Electronic address: dr.martin.reck@web.de.

Free article

Comment

Xin Huang et al. J Thorac Oncol. 2017 Nov.

Free article

. 2017 Nov;12(11):e192.

doi: 10.1016/j.jtho.2017.08.018.

¹ Discovery and Early Pipeline Statistics, Abbvie, Inc., North Chicago, Illinoiis.
² Thoracic Oncology, Hospital Grosshansdorf, Grosshansdorf, Germany. Electronic address: dr.martin.reck@web.de.

No abstract available

Comment on

Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases.
Lodeweges JE, Klinkenberg TJ, Ubbels JF, Groen HJM, Langendijk JA, Widder J. Lodeweges JE, et al. J Thorac Oncol. 2017 Sep;12(9):1442-1445. doi: 10.1016/j.jtho.2017.05.015. Epub 2017 May 30. J Thorac Oncol. 2017. PMID: 28576747
Long-Term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligo-recurrence.
Niibe Y, Jingu K, Onishi H. Niibe Y, et al. J Thorac Oncol. 2017 Nov;12(11):e191. doi: 10.1016/j.jtho.2017.07.035. J Thorac Oncol. 2017. PMID: 29074214 No abstract available.
Synchronous or Metachronous Oligometastases.
Widder J, Lodeweges J. Widder J, et al. J Thorac Oncol. 2017 Nov;12(11):e191-e192. doi: 10.1016/j.jtho.2017.08.020. J Thorac Oncol. 2017. PMID: 29074215 No abstract available.